Benefits of Glucomannan

Evidence-Based Benefits

• Weight loss — a meta-analysis (Keithley & Swanson, 2005, 5 RCTs) found glucomannan significantly reduced body weight vs placebo, with mean loss of ~0.8 kg over 5 weeks
• EFSA health claim — the European Food Safety Authority approved the claim that glucomannan contributes to weight loss in the context of an energy-restricted diet (3 g/day)
• Cholesterol reduction — glucomannan reduces total and LDL cholesterol by 7-10% through bile acid binding (Sood et al., 2008)
• Blood sugar control — the viscous gel slows carbohydrate absorption, reducing postprandial glucose spikes (Vuksan et al., 2000)

What the Research Says

Glucomannan is a soluble dietary fiber derived from konjac root, offering potential health benefits. The European Food Safety Authority (EFSA) has approved its use in weight management, noting its ability to promote satiety and reduce calorie intake when consumed before meals with water (EFSA Panel on Dietetic Products, Nutrition and Allergies, 2010). However, evidence supporting glucomannan's effectiveness for weight loss is inconsistent. A systematic review by Onakpoya et al. (2014) found no statistically significant weight loss effect compared to placebo (-0.22 kg; 95% CI, -0.62, 0.19), while other studies suggest modest benefits under specific conditions.

Glucomannan has demonstrated beneficial effects on lipid profiles. A systematic review and meta-analysis by Haijun et al. (2025) involving 18 studies with 1,234 adults showed significant reductions in total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C). Similarly, Musazadeh et al. (2024) reported significant decreases in TC and LDL-C levels in adults following glucomannan supplementation. These findings align with earlier work by Ho et al. (2017), who found that konjac glucomannan significantly reduced LDL cholesterol (-0.35 mmol/L, p<0.001) and non-HDL cholesterol (-0.32 mmol/L, p<0.001).

Regarding digestive health, Han et al. (2017) conducted a systematic review and meta-analysis of three RCTs involving 122 children, concluding that glucomannan modestly increased defecation frequency but did not improve stool consistency or treatment success rates for functional constipation.

Overall, glucomannan appears to offer benefits for cholesterol management and may support weight management under specific conditions, though its effects on body weight are not universally significant.

Related Conditions